Similar articles

• Perioperative chemotherapy for gastric cancer: how should we measure the efficacy?

  Persiani R, Rausei S, Biondi A, D'Ugo D. Persiani R, et al. Ann Surg Oncol. 2009 Apr;16(4):1077-9. doi: 10.1245/s10434-008-0310-7. Epub 2009 Jan 24. Ann Surg Oncol. 2009. PMID: 19169756 No abstract available.
• Perioperative chemotherapy for gastric cancer.

  Fatourou E, Macheras A, Misiakos EP, Liakakos T. Fatourou E, et al. Ann Surg Oncol. 2009 Jan;16(1):226-7. doi: 10.1245/s10434-008-0117-6. Epub 2008 Sep 5. Ann Surg Oncol. 2009. PMID: 18773245 No abstract available.
• Chemotherapy in gastric cancer.

  Wöll E, Devries A, Eisterer W, Hejna M, Keil F, Stein H, Zacherl J, Greil R. Wöll E, et al. Anticancer Res. 2008 Mar-Apr;28(2B):1213-9. Anticancer Res. 2008. PMID: 18505058 Review.
• [Neoadjuvant chemotherapy for gastric cancer].

  Fujii M, Kochi M, Takayama T. Fujii M, et al. Gan To Kagaku Ryoho. 2007 Oct;34(10):1549-52. Gan To Kagaku Ryoho. 2007. PMID: 17940370 Review. Japanese.
• [Clinical case: perioperative chemotherapy of gastric cancer: for whom? which risks?].

  Michel P. Michel P. Gastroenterol Clin Biol. 2009 Apr;33(4):280-4. doi: 10.1016/j.gcb.2009.02.012. Epub 2009 Apr 3. Gastroenterol Clin Biol. 2009. PMID: 19345537 French. No abstract available.